BIOPHEN Heparin Anti-IIa (2 Stages) - Replaced by A220005
Chromogenic anti-IIa method for measuring homogeneously heparin in plasma (tested diluted 1:25) or in purified systems, using a two-stage method. Offers a wide measurement range from 0 to 1 IU/mL for plasma, or from 0.002 to 0.04 IU/mL for purified systems and is appropriate for testing heparins for their anti-thrombin activity. This assay is in compliance with USP Anti-FIIa assay for unfractionated heparin.
Please see important notification letter from the manufacturer regarding the use of this product.
For the measurement of heparin anti-thrombin activity in research applications.
This assay, using a predilution of Antithrombin and Thrombin reagents in R4 buffer, is in compliance with the USP Anti-Factor IIa assay for unfractionated heparin.
Please Note: Results obtained should be for research purposes only and not used for patient diagnosis or treatment.
Instructions For Use
Material Safety Data Sheet (MSDS)
Certificate of Analysis (COA)